Autistic spectrum disorders: A review of clinical features, theories and diagnosis

International Journal of Developmental Neuroscience

Volumn 43, Issue , 2015, Pages 70-77

  Fakhoury, Marc ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Autism spectrum disorder; Behavior; Brain development; Diagnosis; Genetics

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR ALPHA5; 4 AMINOBUTYRIC ACID A RECEPTOR BETA3; 4 AMINOBUTYRIC ACID A RECEPTOR GAMMA3; BIOLOGICAL MARKER; GLUTAMIC ACID; INTERLEUKIN 10; INTERLEUKIN 6; OXYTOCIN; SEROTONIN; TRANSFORMING GROWTH FACTOR ALPHA;

AGGRESSION; ANXIETY DISORDER; AUTISM; AUTOMUTILATION; BRAIN DYSFUNCTION; CLINICAL FEATURE; COMPULSION; CYTOKINE PRODUCTION; DEPRESSION; DIFFUSION TENSOR IMAGING; DSM-5; DSM-IV; ENVIRONMENTAL FACTOR; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GABRA5 GENE; GABRB3 GENE; GABRG3 GENE; GENETIC ASSOCIATION; GENOTYPE ENVIRONMENT INTERACTION; HEREDITY; HUMAN; HYPERACTIVITY; INTELLIGENCE QUOTIENT; LANGUAGE DISABILITY; MIRROR NEURON; NERVE CELL INHIBITION; NERVE CELL PLASTICITY; NERVE CELL STIMULATION; NEUROPATHOLOGY; NEUROTRANSMITTER RELEASE; NONHUMAN; OXYTOCIN BLOOD LEVEL; PRIORITY JOURNAL; RECEPTOR GENE; REVIEW; SEMI STRUCTURED INTERVIEW; SOCIAL INTERACTION; STEREOTYPY; SYNAPTIC TRANSMISSION; THEORY OF MIND; AUTISM SPECTRUM DISORDER; BRAIN; GENETICS; GROWTH, DEVELOPMENT AND AGING; PATHOLOGY;

AUTISM SPECTRUM DISORDER; BRAIN; GENE-ENVIRONMENT INTERACTION; GENETICS; HUMANS;

EID: 84928730099     PISSN: 07365748     EISSN: 1873474X     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2015.04.003     Document Type: Review

References (128)

1. Akshoomoff N., Corsello C., Schmidt H. The role of the autism diagnostic observation schedule in the assessment of autism spectrum disorders in school and community settings. Calif. School Psychol. 2006, 11:7-19.
2. Al-Farsi Y.M., Waly M.I., Deth R.C., Al-Sharbati M.M., Al-Shafaee M., Al-Farsi O., et al. Low folate and vitamin B12 nourishment is common in Omani children with newly diagnosed autism. Nutrition 2013, 29(3):537-541.
3. Alabdali A., Al-Ayadhi L., El-Ansary A. Association of social and cognitive impairment and biomarkers in autism spectrum disorders. J. Neuroinflamm. 2014, 11:4.
4. Aldred S., Moore K.M., Fitzgerald M., Waring R.H. Plasma amino acid levels in children with autism and their families. J. Autism Dev. Disord. 2003, 33(1):93-97.
5. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders: DSM-IV 1994, American Psychiatric Association, Washington, DC. 4th ed.
6. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2013, American Psychiatric Association, Washington, DC. 5th ed.
7. Baron-Cohen S., Leslie A.M., Frith U. Does the autistic child have a theory of mind?. Cognition 1985, 21(1):37-46.
8. Baron-Cohen S., Ring H., Moriarty J., Schmitz B., Costa D., Ell P. Recognition of mental state terms. Clinical findings in children with autism and a functional neuroimaging study of normal adults. Br. J. Psychiatry 1994, 165(5):640-649.
9. Barton M.L., Robins D.L., Jashar D., Brennan L., Fein D. Sensitivity and specificity of proposed DSM-5 criteria for autism spectrum disorder in toddlers. J. Autism Dev. Disord. 2013, 43(5):1184-1195.
10. Bernier R., Aaronson B., McPartland J. The role of imitation in the observed heterogeneity in EEG mu rhythm in autism and typical development. Brain Cogn. 2013, 82(1):69-75.
11. Black M.M. Effects of vitamin B12 and folate deficiency on brain development in children. Food Nutr. Bull. 2008, 29(2 Suppl):S126-S131.
12. Blatt G.J., Fatemi S.H. Alterations in GABAergic biomarkers in the autism brain: research findings and clinical implications. Anat. Rec. (Hoboken) 2011, 294(10):1646-1652.
13. Bolton P.F., Park R.J., Higgins J.N., Griffiths P.D., Pickles A. Neuro-epileptic determinants of autism spectrum disorders in tuberous sclerosis complex. Brain 2002, 125(Pt 6):1247-1255.
14. Boraston Z., Blakemore S.J. The application of eye-tracking technology in the study of autism. J. Physiol. 2007, 581(Pt 3):893-898.
15. Brentani H., Paula C.S., Bordini D., Rolim D., Sato F., Portolese J., et al. Autism spectrum disorders: an overview on diagnosis and treatment. Rev. Bras. Psiquiatr. 2013, 35(Suppl. 1):S62-72.
16. Brune C.W., Kim S.J., Salt J., Leventhal B.L., Lord C., Cook E.H. 5-HTTLPR genotype-specific phenotype in children and adolescents with autism. Am. J. Psychiatry 2006, 163(12):2148-2156.
17. Buescher A.V., Cidav Z., Knapp M., Mandell D.S. Costs of autism spectrum disorders in the United Kingdom and the United States. JAMA Pediatr. 2014, 168(8):721-728.
18. Cattaneo L., Fabbri-Destro M., Boria S., Pieraccini C., Monti A., Cossu G., et al. Impairment of actions chains in autism and its possible role in intention understanding. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(45):17825-17830.
19. Chaste P., Leboyer M. Autism risk factors: genes, environment, and gene-environment interactions. Dialogues Clin. Neurosci. 2012, 14(3):281-292.
20. Chlebowski C., Green J.A., Barton M.L., Fein D. Using the childhood autism rating scale to diagnose autism spectrum disorders?. J. Autism Dev. Disord. 2010, 40(7):787-799.
21. Claes P., Walters M., Vandermeulen D., Clement J.G. Spatially-dense 3D facial asymmetry assessment in both typical and disordered growth. J. Anat. 2011, 219(4):444-455.
22. Courchesne E., Carper R., Akshoomoff N. Evidence of brain overgrowth in the first year of life in autism. JAMA 2003, 290(3):337-344.
23. Croen L.A., Grether J.K., Yoshida C.K., Odouli R., Hendrick V. Antidepressant use during pregnancy and childhood autism spectrum disorders. Arch. Gen. Psychiatry 2011, 68(11):1104-1112.
24. Curatolo P., Napolioni V., Moavero R. Autism spectrum disorders in tuberous sclerosis: pathogenetic pathways and implications for treatment. J. Child Neurol. 2010, 25(7):873-880.
25. Dapretto M., Davies M.S., Pfeifer J.H., Scott A.A., Sigman M., Bookheimer S.Y., et al. Understanding emotions in others: mirror neuron dysfunction in children with autism spectrum disorders. Nat. Neurosci. 2006, 9(1):28-30.
26. Dichter G.S. Functional magnetic resonance imaging of autism spectrum disorders. Dialogues Clin. Neurosci. 2012, 14(3):319-351.
27. Dosreis S., Weiner C.L., Johnson L., Newschaffer C.J. Autism spectrum disorder screening and management practices among general pediatric providers. J. Dev. Behav. Pediatr. 2006, 27(2 Suppl):S88-94.
28. Dumas G., Kelso J.A., Nadel J. Tackling the social cognition paradox through multi-scale approaches. Front. Psychol. 2014, 5:882.
29. Egger G., Roetzer K.M., Noor A., Lionel A.C., Mahmood H., Schwarzbraun T., et al. Identification of risk genes for autism spectrum disorder through copy number variation analysis in Austrian families. Neurogenetics 2014, 15(2):117-127.
30. Eliasen M., Tolstrup J.S., Nybo Andersen A.M., Gronbaek M., Olsen J., Strandberg-Larsen K. Prenatal alcohol exposure and autistic spectrum disorders-a population-based prospective study of 80,552 children and their mothers. Int. J. Epidemiol. 2010, 39(4):1074-1081.
31. Enticott P.G., Kennedy H.A., Rinehart N.J., Tonge B.J., Bradshaw J.L., Taffe J.R., et al. Mirror neuron activity associated with social impairments but not age in autism spectrum disorder. Biol. Psychiatr. 2012, 71(5):427-433.
32. Ercan I., Ozdemir S.T., Etoz A., Sigirli D., Tubbs R.S., Loukas M., et al. Facial asymmetry in young healthy subjects evaluated by statistical shape analysis. J. Anat. 2008, 213(6):663-669.
33. Faulk C., Dolinoy D.C. Timing is everything: the when and how of environmentally induced changes in the epigenome of animals. Epigenetics 2011, 6(7):791-797.
34. Fan Y.T., Decety J., Yang C.Y., Liu J.L., Cheng Y. Unbroken mirror neurons in autism spectrum disorders. J. Child Psychol. Psychiatry 2010, 51(9):981-988.
35. Frith U., Morton J., Leslie A.M. The cognitive basis of a biological disorder: autism. Trends Neurosci. 1991, 14(10):433-438.
36. Gabriele S., Sacco R., Persico A.M. Blood serotonin levels in autism spectrum disorder: a systematic review and meta-analysis. Eur. Neuropsychopharmacol. 2014, 24(6):919-929.
37. Gadow K.D., DeVincent C.J., Siegal V.I., Olvet D.M., Kibria S., Kirsch S.F., et al. Allele-specific associations of 5-HTTLPR/rs25531 with ADHD and autism spectrum disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 2013, 40:292-297.
38. Gallese V. Before and below 'theory of mind': embodied simulation and the neural correlates of social cognition. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2007, 362(1480):659-669.
39. Gallese V., Rochat M.J., Berchio C. The mirror mechanism and its potential role in autism spectrum disorder. Dev. Med. Child Neurol. 2013, 55(1):15-22.
40. Gardener H., Spiegelman D., Buka S.L. Prenatal risk factors for autism: comprehensive meta-analysis. Br. J. Psychiatry 2009, 195(1):7-14.
41. Geier D.A., Kern J.K., Geier M.R. A comparison of the autism treatment evaluation checklist (ATEC) and the childhood autism rating scale (CARS) for the quantitative evaluation of autism. J. Ment. Health Res. Intellect. Disabil. 2013, 6(4):255-267.
42. Geschwind D.H. Genetics of autism spectrum disorders. Trends Cogn. Sci. 2011, 15(9):409-416.
43. Gillott A., Furniss F., Walter A. Anxiety in high-functioning children with autism. Autism 2001, 5(3):277-286.
44. Gotham K., Risi S., Dawson G., Tager-Flusberg H., Joseph R., Carter A., et al. A replication of the autism diagnostic observation schedule (ADOS) revised algorithms. J. Am. Acad. Child Adolesc. Psychiatry 2008, 47(6):642-651.
45. Grant W.B., Cannell J.J. Autism prevalence in the United States with respect to solar UV-B doses: an ecological study. Dermatoendocrinology 2013, 5(1):159-164.
46. Grzadzinski R., Huerta M., Lord C. DSM-5 and autism spectrum disorders (ASDs): an opportunity for identifying ASD subtypes. Mol. Autism 2013, 4(1):12.
47. Hammond P. The use of 3D face shape modelling in dysmorphology. Arch. Dis. Child 2007, 92(12):1120-1126.
48. Hammock E., Veenstra-VanderWeele J., Yan Z., Kerr T.M., Morris M., Anderson G.M., et al. Examining autism spectrum disorders by biomarkers: example from the oxytocin and serotonin systems. J. Am. Acad. Child Adolesc. Psychiatry 2012, 51(7):712-721.
49. Hammond P., Forster-Gibson C., Chudley A.E., Allanson J.E., Hutton T.J., Farrell S.A., et al. Face-brain asymmetry in autism spectrum disorders. Mol. Psychiatry 2008, 13(6):614-623.
50. Herbert M.R., Ziegler D.A., Deutsch C.K., O'Brien L.M., Lange N., Bakardjiev A., et al. Dissociations of cerebral cortex: subcortical and cerebral white matter volumes in autistic boys. Brain 2003, 126(Pt 5):1182-1192.
51. Holt R., Barnby G., Maestrini E., Bacchelli E., Brocklebank D., Sousa I., et al. Linkage and candidate gene studies of autism spectrum disorders in European populations. Eur. J. Hum. Genet. 2010, 18(9):1013-1019.
52. Hu V.W., Steinberg M.E. Novel clustering of items from the autism diagnostic interview-revised to define phenotypes within autism spectrum disorders. Autism Res. 2009, 2(2):67-77.
53. Huerta M., Bishop S.L., Duncan A., Hus V., Lord C. Response to Ritvo and Ritvo letter. Am. J. Psychiatry 2013, 170(4):445-446.
54. Hunter D.J. Gene-environment interactions in human diseases. Nat. Rev. Genet. 2005, 6(4):287-298.
55. Iossifov I., Ronemus M., Levy D., Wang Z., Hakker I., Rosenbaum J., et al. De novo gene disruptions in children on the autistic spectrum. Neuron 2012, 74(2):285-299.
56. Jia F., Wang B., Shan L., Xu Z., Staal W.G., Du L. Core symptoms of autism improved after vitamin D supplementation. Pediatrics 2015, 135(1):e196-8.
57. Just M.A., Keller T.A., Malave V.L., Kana R.K., Varma S. Autism as a neural systems disorder: a theory of frontal-posterior underconnectivity. Neurosci. Biobehav. Rev. 2012, 36(4):1292-1313.
58. Jutras-Aswad D., DiNieri J.A., Harkany T., Hurd Y.L. Neurobiological consequences of maternal cannabis on human fetal development and its neuropsychiatric outcome. Eur. Arch. Psychiatry Clin. Neurosci. 2009, 259(7):395-412.
59. Kaat A.J., Gadow K.D., Lecavalier L. Psychiatric symptom impairment in children with autism spectrum disorders. J. Abnorm. Child Psychol. 2013, 41(6):959-969.
60. Kana R.K., Uddin L.Q., Kenet T., Chugani D., Müller R.A. Brain connectivity in autism. Front. Hum. Neurosci. 2014, 8:349.
61. Keehn B., Wagner J.B., Tager-Flusberg H., Nelson C.A. Functional connectivity in the first year of life in infants at-risk for autism: a preliminary near-infrared spectroscopy study. Front. Hum. Neurosci. 2013, 7:444.
62. Kim S.A., Kim J.H., Park M., Cho I.H., Yoo H.J. Association of GABRB3 polymorphisms with autism spectrum disorders in Korean trios. Neuropsychobiology 2006, 54(3):160-165.
63. Kim Y.S., Leventhal B.L., Koh Y.J., Fombonne E., Laska E., Lim E.C., et al. Prevalence of autism spectrum disorders in a total population sample. Am. J. Psychiatry 2011, 168(9):904-912.
64. Klauck S.M. Genetics of autism spectrum disorder. Eur. J. Hum. Genet. 2006, 14(6):714-720.
65. Lai M.C., Lombardo M.V., Baron-Cohen S. Autism. Lancet 2014, 383(9920):896-910.
66. Larsson M., Weiss B., Janson S., Sundell J., Bornehag C.G. Associations between indoor environmental factors and parental-reported autistic spectrum disorders in children 6-8 years of age. Neurotoxicology 2009, 30(5):822-831.
67. Levy S.E., Mandell D.S., Schultz R.T. Autism. Lancet 2009, 374(9701):1627-1638.
68. Lord C., Petkova E., Hus V., Gan W., Lu F., Martin D.M., et al. A multisite study of the clinical diagnosis of different autism spectrum disorders. Arch. Gen. Psychiatry 2012, 69(3):306-313.
69. Lord C., Risi S., Lambrecht L., Cook E.H., Leventhal B.L., DiLavore P.C., et al. The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism. J. Autism Dev. Disord. 2000, 30(3):205-223.
70. Lyall K., Schmidt R.J., Hertz-Picciotto I. Maternal lifestyle and environmental risk factors for autism spectrum disorders. Int. J. Epidemiol. 2014, 43(2):443-464.
71. Mazina V., Gerdts J., Trinh S., Ankenman K., Ward T., Dennis M.Y. Epigenetics of autism-related impairment: copy number variation and maternal infection. J. Dev. Behav. Pediatr. 2015, 36(2):61-67.
72. Mazza M., Pino M.C., Mariano M., Tempesta D., Ferrara M., De Berardis D., et al. Affective and cognitive empathy in adolescents with autism spectrum disorder. Front. Hum. Neurosci. 2014, 8:791.
73. Mazurek M.O., Handen B.L., Wodka E.L., Nowinski L., Butter E., Engelhardt C.R. Age at first autism spectrum disorder diagnosis: the role of birth cohort, demographic factors, and clinical features. J. Dev. Behav. Pediatr. 2014, 35(9):561-569.
74. McCauley J.L., Olson L.M., Dowd M., Amin T., Steele A., Blakely R.D., et al. Linkage and association analysis at the serotonin transporter (SLC6A4) locus in a rigid-compulsive subset of autism. Am. J. Med. Genet. Part B, Neuropsychiatr. Genet. 2004, 127B(1):104-112.
75. Mercadante M.T., Macedo E.C., Baptista P.M., Paula C.S., Schwartzman J.S. Saccadic movements using eye-tracking technology in individuals with autism spectrum disorders: pilot study. Arq. Neuropsiquiatr. 2006, 64(3A):559-562.
76. Moran J.M., Young L.L., Saxe R., Lee S.M., O'Young D., Mavros P.L., et al. Impaired theory of mind for moral judgment in high-functioning autism. Proc. Natl. Acad. Sci. U. S. A. 2011, 108(7):2688-2692.
77. Muhle R., Trentacoste S.V., Rapin I. The genetics of autism. Pediatrics 2004, 113(5):e472-86.
78. Muller R.A., Shih P., Keehn B., Deyoe J.R., Leyden K.M., Shukla D.K. Underconnected, but how? A survey of functional connectivity MRI studies in autism spectrum disorders. Cereb. Cortex 2011, 21(10):2233-2243.
79. Murdoch J.D., State M.W. Recent developments in the genetics of autism spectrum disorders. Curr. Opin. Genet. Dev. 2013, 23(3):310-315.
80. Murphy D.L., Lesch K.P. Targeting the murine serotonin transporter: insights into human neurobiology. Nat. Rev. Neurosci. 2008, 9(2):85-96.
81. Nakamura K., Sekine Y., Ouchi Y., Tsujii M., Yoshikawa E., Futatsubashi M., et al. Brain serotonin and dopamine transporter bindings in adults with high-functioning autism. Arch. Gen. Psychiatry 2010, 67(1):59-68.
82. Napolioni V., Curatolo P. Genetics and molecular biology of tuberous sclerosis complex. Curr. Genomics 2008, 9(7):475-487.
83. Nardone S., Sams D.S., Reuveni E., Getselter D., Oron O., Karpuj M., et al. DNA methylation analysis of the autistic brain reveals multiple dysregulated biological pathways. Transl. Psychiatry 2014, 4:e433.
84. Nazeer A., Ghaziuddin M. Autism spectrum disorders: clinical features and diagnosis. Pediatr. Clin. North Am. 2012, 59(1):19-25.
85. Newschaffer C.J., Croen L.A., Daniels J., Giarelli E., Grether J.K., Levy S.E., et al. The epidemiology of autism spectrum disorders. Annu. Rev. Public Health 2007, 28:235-258.
86. Niculescu M.D., Craciunescu C.N., Zeisel S.H. Dietary choline deficiency alters global and gene-specific DNA methylation in the developing hippocampus of mouse fetal brains. FASEB J. 2006, 20(1):43-49.
87. Oberman L.M., Hubbard E.M., McCleery J.P., Altschuler E.L., Ramachandran V.S., Pineda J.A. EEG evidence for mirror neuron dysfunction in autism spectrum disorders. Brain Res. Cogn. Brain Res. 2005, 24(2):190-198.
88. Persico A.M., Napolioni V. Autism genetics. Behav. Brain Res. 2013, 251:95-112.
89. Peterson C. Theory of mind understanding and empathic behavior in children with autism spectrum disorders. Int. J. Dev. Neurosci. 2014, 39:16-21.
90. Pileggi L.A., Malcolm-Smith S., Solms M. Investigating the role of social-affective attachment processes in cradling bias: the absence of cradling bias in children with autism spectrum disorders. Laterality 2015, 20(2):154-170.
91. Pizzarelli R., Cherubini E. Alterations of GABAergic signaling in autism spectrum disorders. Neural Plast. 2011, 2011(297153):1-12.
92. Polsek D., Jagatic T., Cepanec M., Hof P.R., Simic G. Recent developments in neuropathology of autism spectrum disorders. Transl. Neurosci. 2011, 2(3):256-264.
93. Rabbani B., Mahdieh N., Hosomichi K., Nakaoka H., Inoue I. Next-generation sequencing: impact of exome sequencing in characterizing Mendelian disorders. J. Hum. Genet. 2012, 57(10):621-632.
94. Rabbani B., Tekin M., Mahdieh N. The promise of whole-exome sequencing in medical genetics. J. Hum. Genet. 2014, 59(1):5-15.
95. Randolph-Gips M., Srinivasan P. Modeling autism: a systems biology approach. J. Clin. Bioinf. 2012, 2(1):17.
96. Reaven J.A., Hepburn S.L., Ross R.G. Use of the ADOS and ADI-R in children with psychosis: importance of clinical judgment. Clin. Child Psychol. Psychiatry 2008, 13(1):81-94.
97. Rizzolatti G., Fabbri-Destro M. Mirror neurons: from discovery to autism. Exp. Brain Res 2010, 200(3-4):223-237.
98. Rizzolatti G., Fabbri-Destro M., Cattaneo L. Mirror neurons and their clinical relevance. Nat. Clin. Pract. Neurol. 2009, 5(1):24-34.
99. Ronald A., Hoekstra R.A. Autism spectrum disorders and autistic traits: a decade of new twin studies. Am. J. Med. Genet. Part B, Neuropsychiatr. Genet. 2011, 156B(3):255-274.
100. Ross H.E., Guo Y., Coleman K., Ousley O., Miller A.H. Association of IL-12p70 and IL-6:IL-10 ratio with autism-related behaviors in 22q11.2 deletion syndrome: a preliminary report. Brain Behav. Immun. 2013, 31:76-81.
101. Rubenstein J.L., Merzenich M.M. Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav. 2003, 2(5):255-267.
102. Ruggeri B., Sarkans U., Schumann G., Persico A.M. Biomarkers in autism spectrum disorder: the old and the new. Psychopharmacology (Berl.) 2014, 231(6):1201-1216.
103. Sanders S.J., Murtha M.T., Gupta A.R., Murdoch J.D., Raubeson M.J., Willsey A.J., et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 2012, 485(7397):237-241.
104. Schaevitz L.R., Berger-Sweeney J.E. Gene-environment interactions and epigenetic pathways in autism: the importance of one-carbon metabolism. ILAR J. 2012, 53(3-4):322-340.
105. Schauder K.B., Muller C.L., Veenstra-VanderWeele J., Cascio C.J. Genetic variation in serotonin transporter modulates tactile hyperresponsiveness in ASD. Res. Autism Spectr. Disord. 2015, 10:93-100.
106. Scheeren A.M., de Rosnay M., Koot H.M., Begeer S. Rethinking theory of mind in high-functioning autism spectrum disorder. J. Child Psychol. Psychiatry 2013, 54(6):628-635.
107. Schumann C.M., Bloss C.S., Barnes C.C., Wideman G.M., Carper R.A., Akshoomoff N., et al. Longitudinal magnetic resonance imaging study of cortical development through early childhood in autism. J. Neurosci. 2010, 30(12):4419-4427.
108. Shimmura C., Suda S., Tsuchiya K.J., Hashimoto K., Ohno K., Matsuzaki H., et al. Alteration of plasma glutamate and glutamine levels in children with high-functioning autism. PLoS One 2011, 6(10):e25340.
109. Solomon M., Ozonoff S.J., Ursu S., Ravizza S., Cummings N., Ly S., et al. The neural substrates of cognitive control deficits in autism spectrum disorders. Neuropsychologia 2009, 47(12):2515-2526.
110. Stoppelbein L., Greening L., Kakooza A. The importance of catatonia and stereotypies in autistic spectrum disorders. Int. Rev. Neurobiol. 2006, 72:103-118.
111. Sudhof T.C. Neuroligins and neurexins link synaptic function to cognitive disease. Nature 2008, 455(7215):903-911.
112. Szpir M. Tracing the origins of autism: a spectrum of new studies. Environ. Health Perspect. 2006, 114(7):A412-8.
113. Takahashi H., Katayama K., Sohya K., Miyamoto H., Prasad T., Matsumoto Y., et al. Selective control of inhibitory synapse development by Slitrk3-PTPδ trans-synaptic interaction. Nat. Neurosci. 2012, 15(3):S1-S2. 389-398.
114. Tordjman S., Somogyi E., Coulon N., Kermarrec S., Cohen D., Bronsard G., et al. Gene×environment interactions in autism spectrum disorders: role of epigenetic mechanisms. Front. Psychiatry 2014, 5:53.
115. Tran P.L., Lehti V., Lampi K.M., Helenius H., Suominen A., Gissler M., et al. Smoking during pregnancy and risk of autism spectrum disorder in a Finnish national birth cohort. Paediatr. Perinat. Epidemiol. 2013, 27(3):266-274.
116. Tuchman R., Rapin I. Epilepsy in autism. Lancet Neurol. 2002, 1(6):352-358.
117. Vargas D.L., Nascimbene C., Krishnan C., Zimmerman A.W., Pardo C.A. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann. Neurol. 2005, 57(1):67-81.
118. Volk H.E., Kerin T., Lurmann F., Hertz-Picciotto I., McConnell R., Campbell D.B. Autism spectrum disorder: interaction of air pollution with the MET receptor tyrosine kinase gene. Epidemiology 2014, 25(1):44-47.
119. Vorstman J.A., Staal W.G., van Daalen E., van Engeland H., Hochstenbach P.F., Franke L. Identification of novel autism candidate regions through analysis of reported cytogenetic abnormalities associated with autism. Mol. Psychiatry 2006, 11(1):18-28.
120. Weitlauf A.S., Gotham K.O., Vehorn A.C., Warren Z.E. Brief report: DSM-5 levels of support: a comment on discrepant conceptualizations of severity in ASD. J. Autism Dev. Disord. 2014, 44(2):471-476.
121. Wiggins J.L., Swartz J.R., Martin D.M., Lord C., Monk C.S. Serotonin transporter genotype impacts amygdala habituation in youth with autism spectrum disorders. Soc. Cogn. Affect Neurosci. 2014, 9(6):832-838.
122. Williams J.H., Whiten A., Suddendorf T., Perrett D.I. Imitation, mirror neurons and autism. Neurosci. Biobehav. Rev. 2001, 25(4):287-295.
123. Wills S., Cabanlit M., Bennett J., Ashwood P., Amaral D., Van de Water J. Autoantibodies in autism spectrum disorders (ASD). Ann. N.Y. Acad. Sci. 2007, 1107:79-91.
124. Wing L., Shah A. Catatonia in autistic spectrum disorders. Br. J. Psychiatry 2000, 176:357-362.
125. Yap I.K., Angley M., Veselkov K.A., Holmes E., Lindon J.C., Nicholson J.K. Urinary metabolic phenotyping differentiates children with autism from their unaffected siblings and age-matched controls. J. Proteome Res. 2010, 9(6):2996-3004.
126. Zeisel S.H. The supply of choline is important for fetal progenitor cells. Semin. Cell Dev. Biol. 2011, 22(6):624-628.
127. Zhu L., Wang X., Li X.L., Towers A., Cao X., Wang P., et al. Epigenetic dysregulation of SHANK3 in brain tissues from individuals with autism spectrum disorders. Hum. Mol. Genet. 2014, 23(6):1563-1578.
128. Zilina O., Teek R., Tammur P., Kuuse K., Yakoreva M., Vaidla E., et al. Chromosomal microarray analysis as a first-tier clinical diagnostic test: estonian experience. Mol. Genet. Genomic Med. 2014, 2(2):166-175.